patients for whom alternative treatment options (e.g., non ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CONZIP® safely and effectively. See full precribing information for s
Download patients for whom alternative treatment options (e.g., non ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
PRODUCT MONOGRAPH INCLUDING CONSUMER …
products.sanofi.caPRODUCT MONOGRAPH . INCLUDING CONSUMER INFORMATION . PrNOZINAN . Methotrimeprazine Hydrochloride Injection, USP. 25 mg/mL methotrimeprazine as …
PRODUCT MONOGRAPH INCLUDING PATIENT …
purdue.caFOQUEST™ (methylphenidate hydrochloride CR capsules) Page 1 of 37 . PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . FOQUEST™ methylphenidate hydrochloride
Participating Hospital Certification Form
amtrial.comPlease see accompanying FULL PRESCRIBING INFORMATION, including BOXED WARNING. Page 6 of 6 IMPORTANT SAFETY INFORMATION for ABILIFY MAINTENA® (aripiprazole) (Continued) Orthostatic Hypotension: ABILIFY MAINTENA may cause orthostatic hypotension and should be used with caution in patients with known cardiovascular disease, cerebrovascular disease, or conditions …
Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets
medsafe.govt.nz1 Nortriptyline NRIM 09052013 NEW ZEALAND DATA SHEET Nortriptyline NRIM . Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets . This product may not be interchangeable with similar products on the New Zealand market
Brief Overview of Common Psychotropic Medications
secure.ce-credit.comBrief Overview of Common Psychotropic Medications: A Practical Guide from a Clinical Viewpoint Paula Bank, M.D., Ph.D. Dept. of Psychiatry University of Michigan
HIGHLIGHTS OF PRESCRIBING INFORMATION hypotension, …
www.astellas.usFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE LEXISCAN® (regadenoson) injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.pi.amgen.com4 Patients with congenital long QT syndrome, history of QT interval prolongation, family history of long QT syndrome or sudden cardiac death, and other conditions that predispose to QT interval prolongation and